Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Shirotake

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
In Vitro|June 1, 1983
Establishment and properties of a human choriocarcinoma cell line of ovarian originS Sekiya, T Kaiho, S Shirotake, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Neutrophil to lymphocyte ratio and tumour burden for treatment efficacy stratification in renal cell carcinoma patients receiving nivolumab plus ipilimumabM Oshima, S Washino, S Shirotake, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
In Vitro|June 1, 1983
Establishment and properties of a human choriocarcinoma cell line of ovarian originS Sekiya, T Kaiho, S Shirotake, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Neutrophil to lymphocyte ratio and tumour burden for treatment efficacy stratification in renal cell carcinoma patients receiving nivolumab plus ipilimumabM Oshima, S Washino, S Shirotake, et al.
Pageof 4